blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3290036

EP3290036 - STABILIZED PHARMACEUTICAL COMPOSITION [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  07.08.2020
Database last updated on 14.09.2024
FormerExamination is in progress
Status updated on  13.05.2020
FormerRequest for examination was made
Status updated on  02.02.2018
FormerThe international publication has been made
Status updated on  04.11.2016
Most recent event   Tooltip07.08.2020Withdrawal of applicationpublished on 09.09.2020  [2020/37]
Applicant(s)For all designated states
Astellas Pharma Inc.
5-1, Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411 / JP
[2018/10]
Inventor(s)01 / TASAKI, Hiroaki
c/o Astellas Pharma Inc.
5-1 Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411 / JP
02 / YOSHIDA, Mitsuru
c/o Astellas Pharma Inc.
5-1 Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411 / JP
03 / TSUNASHIMA, Daisuke
c/o Astellas Pharma Inc.
5-1 Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411 / JP
04 / AZUMA, Ryota
c/o Astellas Pharma Inc.
5-1 Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411 / JP
 [2018/10]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2018/10]
Application number, filing date16786469.326.04.2016
[2018/10]
WO2016JP63004
Priority number, dateJP2015009070227.04.2015         Original published format: JP 2015090702
JP2015025295825.12.2015         Original published format: JP 2015252958
[2018/10]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016175192
Date:03.11.2016
Language:JA
[2016/44]
Type: A1 Application with search report 
No.:EP3290036
Date:07.03.2018
Language:EN
[2018/10]
Search report(s)International search report - published on:JP03.11.2016
(Supplementary) European search report - dispatched on:EP03.12.2018
ClassificationIPC:A61K9/48, A61K31/497, A61K47/04, A61K47/26, A61K47/36, A61K47/38, A61P35/00
[2019/01]
CPC:
A61K47/26 (EP,KR,US); A61K9/4858 (EP,KR,US); A61K31/497 (EP,KR,US);
A61K47/02 (EP,US); A61K47/36 (EP,KR,US); A61K47/38 (EP,KR,US);
A61K9/48 (US); A61K9/4816 (US); A61K9/485 (EP,US);
A61K9/4866 (EP,KR,US); A61P35/00 (EP); A61P43/00 (EP) (-)
Former IPC [2018/10]A61K31/497, A61K9/48, A61K47/04, A61K47/26, A61K47/36, A61K47/38, A61P35/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/10]
TitleGerman:STABILISIERTE PHARMAZEUTISCHE ZUSAMMENSETZUNG[2018/10]
English:STABILIZED PHARMACEUTICAL COMPOSITION[2018/10]
French:COMPOSITION PHARMACEUTIQUE STABILISÉE[2018/10]
Entry into regional phase09.11.2017Translation filed 
09.11.2017National basic fee paid 
09.11.2017Search fee paid 
09.11.2017Designation fee(s) paid 
09.11.2017Examination fee paid 
Examination procedure09.11.2017Examination requested  [2018/10]
09.11.2017Date on which the examining division has become responsible
24.06.2019Amendment by applicant (claims and/or description)
18.05.2020Despatch of a communication from the examining division (Time limit: M04)
06.08.2020Application withdrawn by applicant  [2020/37]
Fees paidRenewal fee
20.04.2018Renewal fee patent year 03
24.04.2019Renewal fee patent year 04
09.03.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]EP2805940  (ASTELLAS PHARMA INC [JP]) [X] 1,6,7,9,10 * paragraph [0001] * * paragraph [0006] * * paragraph [0019] - paragraph [0023] * * paragraph [0068] * * paragraph [0284] * * paragraph [0285]; example 261 * * example 54; table 105 * * test example 3; paragraph [0126] - paragraph [0128] * * table 3 * * paragraph [0133] - paragraph [0138] * * claims 1,12,13 * [I] 2-5,8,11;
 [XPI]WO2015182628  (ASTELLAS PHARMA INC [JP]) [XP] 1,6,7,9,10 * paragraph [0011] * * paragraph [0059] * * example 7 * [I] 2-5,8,11;
 [E]EP3150206  (ASTELLAS PHARMA INC [JP]) [E] 1,6,7,9,10 * paragraph [0011] * * paragraph [0059] * * example 7 *;
 [A]  - ALI R RAJABI-SIAHBOOMI ET AL, Chapter 13: Excipient selection in oral solid dosage formulations containing moisture sensitive drugs, EXCIPIENT APPLICATIONS IN FORMULATION DESIGN AND DRUG DELIVERY, NEW YORK, NY [U.A.] : SPRINGER, 2013, US, PAGE(S) 385 - 421, (20130101), ISBN 978-1-4614-8431-8, XP009509408 [A] 1-11 * the whole document * * sections 13.5 - 13.6.1; page 396 - page 403 * * section 13.2; page 387 *
 [A]  - HEIDEMANN D R ET AL, "Preformulation studies involving moisture uptake in solid dosage forms", PHARMACEUTICAL RESEARCH, SPRINGER NEW YORK LLC, US, (19910228), vol. 8, no. 3, doi:10.1023/A:1015877011807, ISSN 0724-8741, pages 292 - 297, XP009509474 [A] 1-11 * the whole document * * abstract * * tables 1,3 * * figure 5 * * "Results" * * "Discussion" * * "Conclusions" *

DOI:   http://dx.doi.org/10.1023/A:1015877011807
International search[Y]WO2013108754  (ASTELLAS PHARMA INC [JP]) [Y] 1-11 * , paragraphs [0113], [0295] & JP 5532366 B & US 2014/0323463 A1 paragraph [0304]; table 137 & EP 2805940 A1 *;
 [Y]  - "7-1. Iyakuhin Tenkabutsu', '7-6. Iyakuhin no Rekka to sono Boshi", 7 Seizai no Kihon Mondai, Yakuzaigaku Manual, (19890320), pages 107 - 108, 122, XP 009507186 [Y] 1-11
 [Y]  - Anonymous, "1. Kyushitsu ni yoru Kagaku Henka, Funtai o Chushin to shita Seizaigaku", Powder-based formulation, Fourth Edition, JAPAN, (19760325), pages 233 - 236, XP009508242 [Y] 1-11 * , a whole article *
 [Y]  - OSAMU SHINOZAKI, "Suibun Sokutei Sochi", Pharmacia, (19830900), vol. 19, no. 9, pages 900 - 902, XP 009507025 [Y] 1-11 * , particularly, page 900, column of Hajimeni, page 902, column of Owarini *
 [Y]  - N YUTO SUIWABUTSU, Iyakuhin Tenkabutsu Jiten 2007, (20070725), page 204, XP 009507040 [Y] 2-5 * , a whole article *
 [Y]  - "Yoto Betsu ni Mita Kobunshi Kagobutsu", Jitsuyo Iyakuhin Tenkabutsu, Kagaku Kogyosha, (19740305), pages 104 - 105, XP 009507148 [Y] 4, 5 * , particularly, page 105, upper part *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.